CUSIP: 002120103
Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
10,654,020
-
Share change
-
+484,366
-
Total reported value
-
$33,880,000
-
Price per share
-
$3.18
-
Number of holders
-
41
-
Value change
-
+$1,633,742
-
Number of buys
-
22
-
Number of sells
-
21
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2016
-
Previous quarter:
Q2 2016
Recent filing periods for CUSIP 002120103:
Institutional Holders of ATYR PHARMA INC - COM (LIFE) as of Q3 2016
As of 30 Sep 2016,
ATYR PHARMA INC - COM (LIFE) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,654,020 shares.
The largest 10 holders included
FMR LLC, Polaris Venture Management Co. V, L.L.C., Alyeska Investment Group, L.P., FEDERATED INVESTORS INC /PA/, VANGUARD GROUP INC, Rock Springs Capital Management LP, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., TANG CAPITAL MANAGEMENT LLC, and BlackRock Advisors LLC.
This page lists
41
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.